Home
About
Overview
Sharing Data
ORCID
Help
History (31)
A retrospective cohort study of comorbidity trajectories associated with traumatic brain injury in veterans of the Iraq and Afghanistan wars.
Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'.
A contemporary comparative analysis of immediate postoperative prosthesis placement following below-knee amputation.
Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research.
Sparks IL, Derbyshire KM, Jacobs WR, Morita YS. Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. J Bacteriol. 2023 01 26; 205(1):e0033722.
View in:
PubMed
subject areas
Escherichia coli
Humans
Isoniazid
Mycobacterium smegmatis
Mycobacterium tuberculosis
Tuberculosis
authors with profiles
Yasu S Morita PhD